Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

132 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

NCT07001748

Conditions
Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
View all 78 locations
View Trial Details
Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07043400

Conditions
Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Adenocarcinoma
Locations
  • Ironwood Cancer and Research Centers Chandler Ii Chandler, Arizona, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • UC Health Cancer Care and Hematology Clinic Memorial Hospital Central Colorado Springs, Colorado, United States
  • Bioresearch Partners Holding Hialeah Hospital Hialeah, Florida, United States
View all 95 locations
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 744 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

NCT06131840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • IP Address: City of Hope Investigational Drug Services(IDS) Duarte, California, United States
View all 48 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

NCT07689851

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer (GC), +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Hospital Shenzhen, Guangdong, China
  • Shanxi Cancer Hospital Taiyuan, Shanxi, China
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
View Trial Details

Related conditions